SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors
Wing S, Ray JG, Yau K, et al.
JAMA Intern Med. 2025:e250686.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Wing S, Ray JG, Yau K, et al.
JAMA Intern Med. 2025:e250686.
Leggi
Panchal K, Lawson CA, Shabnam S, et al.
Diabetes Obes Metab. Pub. online 2 May 2025.
Leggi
Eeg-Olofsson K, Nathanson D, Spelman T, et al.
Diabetologia. Pub. online 24 Apr 2025.
Leggi
Chew BH, Ngiam KY
BMC Med. 2025;23(1):244
Leggi
Zhou J, Mychaleckyj JC, Onengut-Gumuscu S, et al.
Diabetologia. Pub. online 23 Apr 2025.
Leggi
Lee CMY, Gibson AA, Nassar N, Colagiuri S Diabetes Obes Metab. Pub. online 23 Apr 2025. Abstract e full text
Leggi
Guo L, Zhang J, An R, et al.
BMC Med. 2025;23(1):234.
Leggi
Raje S, Maiya GA, Padmakumar R, et al.
BMC Endocr Disord. 2025;25(1):117.
Leggi
Abbas MT, Awad K, Farina JM, et al.
JACC Adv. 2025;4(5):101750.
Leggi
Guo Z, Wallace AS, Rooney MR, et al.
Diabetes Obes Metab. Pub. online 21 Apr 2025.
Leggi